My Account
An Era of Accelerated Change: Redefining Treasury for Consumer and Healthcare Companies
Article • April 10, 2026
KEY HIGHLIGHTS
- Over $356 billion in global branded drug sales are at risk due to patent expiry between 2023-2028, pushing pharmaceutical companies to replace 46% of sales by 2033
- Geopolitical instabilities and elevated foreign exchange volatility underscore the urgency for treasury organizations to prioritize currency exposure management and financial stability
- The future of treasury innovation includes greater adoption of digital assets like stablecoins and tokenized deposits to facilitate always-on liquidity and near-instant cross-border payments
Artificial intelligence and digital technologies are transforming treasury functions across the healthcare, consumer, and wellness sectors, impacting revenue, costs, and liquidity. Treasury must evolve from an operational role to a strategic, data-driven capability to navigate challenges like pharmaceutical patent cliffs and changing consumer behaviors. Optimizing working capital, enhancing liquidity management, and adopting advanced treasury practices are crucial for competitive advantage and sustained success in this rapidly evolving environment.
Read the full report
Download the "An Era of Accelerated Change" report
